Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Fate therapeutics, inc. crawled time : 00:00 save search
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Argo Blockchain plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARBK
Published: 2023-02-26 (Crawled : 00:00) - prnewswire.com
ARBKF | $0.1416 103.42% 5.1K
|
n/a
|
| O: -2.36%
H: 7.5%
C: 2.23%
ARBK | $1.5 3.45% 3.33% 300K
|
Information
|
| O: -2.42%
H: 4.66%
C: -2.48%
CCSI | $12.86 -0.39% -0.39% 250K
|
Information
|
| O: -0.09%
H: 0.69%
C: -4.19%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 1.73%
H: 2.8%
C: 2.04%
blockchain trial deadline
GWH DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESS Tech Inc. Investors to Secure Counsel Before Important March 13 Deadline in Securities Class Action Filed by the Firm - GWH
Published: 2023-02-26 (Crawled : 00:00) - prnewswire.com
ARBKF | $0.1416 103.42% 5.1K
|
n/a
|
| O: -2.36%
H: 7.5%
C: 2.23%
ARBK | $1.5 3.45% 3.33% 300K
|
Information
|
| O: -2.42%
H: 4.66%
C: -2.48%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 1.73%
H: 2.8%
C: 2.04%
deadline
Bronstein, Gewirtz & Grossman, LLC Notifies Block, Inc. (f/k/a Square Inc.) (SQ; SQ2; APT) Investors of Class Action and to Actively Participate
Published: 2023-02-01 (Crawled : 00:00) - prnewswire.com
SHC | $10.95 0.46% 0.46% 950K
|
Commercial Services
|
| O: 2.19%
H: 1.93%
C: 0.11%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 2.98%
H: 7.01%
C: 4.12%
ROSEN, A LEADING AND RANKED FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE
Published: 2023-01-24 (Crawled : 00:00) - prnewswire.com
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: -1.56%
H: 14.6%
C: 12.49%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -1.66%
H: 2.06%
C: 1.12%
DAKT | $9.13 -0.98% -0.99% 330K
|
Electronic Technology
|
| O: -0.6%
H: 1.96%
C: -0.3%
deadline
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2022 Financial Results
Published: 2022-07-25 (Crawled : 00:00) - biospace.com/
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.0%
H: 0.35%
C: -0.97%
conference therapeutics results
543CL, Research Associate II/I, Translational Science
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
research
600GV, IT Support Specialist II
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
601SM, Senior Computerized Systems Validation (CSV) Engineer
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
system
602MP, Administrative Assistant & Project Coordinator, Technical Operations
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
603MM, Administrative Assistant, G&A
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
604WC, Administrative Assistant & Office Manager, Clinical Development
Published: 2021-10-20 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.99%
H: 1.83%
C: -1.13%
586SM, Senior Research Associate / Research Associate III, Process Development and Manufacturing Support
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
research
587SM, Senior Training & Compliance Associate / Training & Compliance Associate III, Process Development and Manufacturing Support
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
train
590LK, Senior Director / Director, Clinical Trial Operations & Monitoring
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
trial
591GV, Talent Acquisition Specialist
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
acquisition
592GV, Talent Acquisition Coordinator
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
acquisition
593SW, Culture and Talent Development Specialist
Published: 2021-09-27 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -2.84%
H: 0.83%
C: -2.78%
589BM, Senior Research Associate/ Research Associate, cGMP Cell Line Development
Published: 2021-09-23 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
research chmp
555NB, Associate Scientist / Senior Research Associate, Cellular Reprogramming & Engineering
Published: 2021-08-10 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 1.14%
H: 0.0%
C: -0.2%
research
499WBW, Senior Director / Director, Manufacturing
Published: 2021-04-12 (Crawled : 00:00) - fatetherapeutics.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.01%
H: 6.6%
C: 5.19%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.